The right medicine and the right dose for the right patient.
With advances in genomic testing and genetic research, physicians can now tailor treatment to the individual patient. Medicine based on individual genetic make-up or DNA, called Personalized Medicine can help determine the exact therapy a patient may need.
AccessDX’s abstract “Role of combined germline pharmacogenomic and somatic genomic analysis in personalized cancer therapy” was published online by the American Society of Clinical Oncology (ASCO) as part of their annual meeting, May 29 – June 2 in Chicago. Read full abstract.